Wick Capital Partners »

Viking Therapeutics shares owned by Wick Capital Partners

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Wick Capital Partners from 13F filings

Historical chart of Wick Capital Partners investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Wick Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Wick Capital Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $234k 86k 2.73

More positions owned by Wick Capital Partners

Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Total Stk Mkt (VTI)
Blackrock Etf Trust Ii Ishares Lrg Cap (IVVB)
Ishares Tr Core S&p500 Etf (IVV)
Goldman Sachs Etf Tr Goldman Cap Buff (GBXA)
Ishares Tr Core Msci Total (IXUS)
Ishares Tr Ibonds 27 Etf (IBDS)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Ishares Core Msci Emkt (IEMG)
J P Morgan Exchange Traded F Hedged Equity La (HELO)
Ishares Tr Ibonds Dec2026 (IBDR)
Goldman Sachs Etf Tr S&p 500 Premium (GPIX)
J P Morgan Exchange Traded F Nasdaq Eqt Prem (JEPQ)

View all positions for Wick Capital Partners

Top funds holding Viking Therapeutics

Vanguard Group
BlackRock
Susquehanna International
FMR
State Street Corporation
Citadel Advisors
Jpmorgan Chase & Co
Jane Street
Ameriprise Financial
Two Sigma Investments
Geode Capital Management
Two Sigma Advisers
ExodusPoint Capital Management
Goldman Sachs Group
Bnp Paribas Arbitrage, Snc

View all funds holding Viking Therapeutics